Back to News
Amicus Therapeutics joins IQ Consortium
July 18, 2023
The IQ Consortium is very pleased to welcome its newest member, Amicus Therapeutics.
Based in Philadelphia, Amicus is a global biotechnology company, at the forefront of advancing therapies for a range of rare and devastating diseases.
Amicus will be represented on the IQ Board of Directors by Saroj Ramdas and Elfrida Benjamin.